Our choice for Deal of the Month carries the largest price tag for February, and reflects a recent surge of interest in the Biotechnology sector. It is the largest deal this sector has seen since Amgen (NASDAQ: AMGN) acquired Immunex for $11.1 billion last year. After...
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.